XML 35 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
Debt (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Sep. 09, 2016
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Interest expense   $ 20,465 $ 15,350  
Accretion of debt discount   $ (58,438) (174,629)  
Common stock shares reserved under stock option plan   19,400,765    
February 2017 Loan Agreements [member] | Series F Warrant [Member]        
Interest expense   $ 7,233 2,727  
Accretion of debt discount   $ 58,438 38,959  
Expected life   5 years    
Debt discount   $ 443,286    
February 2017 Loan Agreements [member] | Series F Warrant [Member] | Sierchio and Investor [Member]        
Repayment of note principal       $ 50,000
Accrued interest       $ 1,825
February 2017 Loan Agreements [member] | Series F Warrant [Member] | Sierchio [Member]        
Common stock shares reserved under stock option plan   7,246    
February 2017 Loan Agreements [member] | Series F Warrant [Member] | Investor [Member]        
Common stock shares reserved under stock option plan   7,246    
KCC [Member] | Loan agreement [Member]        
Interest expense   $ 13,232 12,345  
Accretion of debt discount   $ 0 $ 131,799  
Convertible debt financing, Maximum amount $ 700,000      
Interest rate 7.00%      
Debt instrument terms conversion feature

The Note became convertible, at KCC’s sole discretion, into shares of our common stock at conversion rate equal to the lesser of: (i) $1.54, the closing price of our common stock on the day prior to the issuance of the Note or (ii) a 20% discount to the average closing price of our common stock for the five days prior to the date on which KCC elects to convert the Note, subject to a floor price of $1.23 per share.

     
Expected life       5 years
Debt discount       $ 700,000
KCC [Member] | Loan agreement [Member] | Series E Warrant [Member]        
Debt instrument terms conversion feature

Common stock at a purchase price of the lesser of: (i) $1.54, the closing price of the Company’s common stock on the day prior to issuance of the Series E Warrant; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which KCC elects to exercise the Series E Warrant.

     
KCC [Member] | February 2017 Loan Agreements [member] | February 23, 2017 and March 9, 2017 [Member]        
Interest rate   7.00%    
Convertible debt financing, Loan received   $ 395,000    
KCC [Member] | February 2017 Loan Agreements [member] | Sierchio and Investor [Member] | February 23, 2017 and March 9, 2017 [Member]        
Interest rate   7.00%    
Convertible debt financing, Loan received   $ 25,000    
Debt instrument terms conversion feature  

(i) $3.45, the closing price of the Company’s common stock on the day prior to the issuance of the February 2017 Notes or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder(s) elect to convert the February 2017 Note(s), subject to a floor price of $2.76.

   
KCC [Member] | February 2017 Loan Agreements [member] | Series F Warrant [Member]        
Common stock shares reserved under stock option plan   114,493    
KCC [Member] | February 2017 Loan Agreements [member] | Series F Warrant [Member] | Sierchio and Investor [Member]        
Debt instrument terms conversion feature  

(i) $3.45, the closing price of the Company’s common stock on the day prior to issuance of the Series F Warrant; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder elects to exercise their Series F Warrant.